METiS Pharmaceuticals Appoints Mark Herbert as Chief Business Officer
Hand-out
Press Releases
METiS Pharmaceuticals  
March 3, 2025

METiS Pharmaceuticals Appoints Mark Herbert as Chief Business Officer

HANGZHOU, China, March 3, 2025 /PRNewswire/ -- METiS Pharmaceuticals, a clinical-stage, AI-driven biotechnology company specializing in innovative drug delivery technologies, today announced the appointment of Mark Herbert as Chief Business

avatar profile Olean Times Herald

Olean Times Herald


Local & Social